Regulatory Affairs - FarmavitaR - Regulatory affairs network

Regulatory Affairs

The Food Supplements Registration in Albania

Tuesday, 11 August 2009 13:21 FarmavitaR Regulatory Affairs - Europe not-EU

REGULATION FOR THE FOOD SUPPLEMENTS REGISTRATION IN THE REPUBLIC OF ALBANIA

The Regulation for Food Supplements Registration is implemented for the food supplements which are introduced and marketed as alimentary products in the Republic of Albania.

Registration of Herbal Medical Products in Albania

Tuesday, 11 August 2009 13:01 Martina Regulatory Affairs - Europe not-EU

ON THE REGISTRATION OF THE HERBAL MEDICAL PRODUCTS IN THE REPUBLIC OF ALBANIA

FarmavitaR+ brings you a short description of herbal medical products registration procedure in the Republic of Albania.

The whole 4 pages article is available for download at Downloads section of Farmavitar.Net

Registration of the drugs in the Republic of Albania

Thursday, 06 August 2009 13:15 Martina Regulatory Affairs - Europe not-EU

ON THE REGISTRATION OF THE DRUGS IN THE REPUBLIC OF ALBANIA

FarmavitaR+ brings you a short description of drugs registration procedure in the Republic of Albania.

The whole 12 pages article is available for download at Downloads section of Farmavitar.Net

Drug repositioning

Tuesday, 14 July 2009 10:10 Datamonitor Regulatory Affairs - Other issues

Drug repositioning strategies: a different approach to innovation

With increased investment in R&D largely failing to fill drug development pipelines, the pharma industry is looking to get more bang for its R&D buck by generating some return out of failed drug candidates and extra return out of others. Drug re-positioning has become a key strategy for pharmaceutical groups, and according to Datamonitor, this approach is set to become more frequently employed

Russia’s Emerging OTC Market Holds Problems As Well As Promise

Friday, 05 June 2009 09:30 FarmavitaR Regulatory Affairs - Europe not-EU

Russia's Emerging OTC Market Holds Problems As Well As Promise

Russia's rapidly growing over-the-counter market offers pharmaceutical companies a chance to expand their business, but its complex regulations and lengthy registration timelines may hinder entry.

"Russia is one of the biggest pearls," said Amra Pasovic, new and emerging markets regulatory affairs director with Johnson & Johnson Group of Consumer Companies in Russia.